Arax Advisory Partners’s Ambev ABEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$78.6K Buy
25,046
+1,580
+7% +$4.94K ﹤0.01% 2907
2026
Q1
$75.6K Buy
23,466
+16,733
+249% +$47.8K ﹤0.01% 1514
2025
Q4
$16.6K Buy
6,733
+822
+14% +$1.96K ﹤0.01% 2215
2025
Q3
$13.2K Sell
5,911
-6,174
-51% -$14.1K ﹤0.01% 2480
2025
Q2
$29.1K Buy
+12,085
New +$29.4K ﹤0.01% 1490
2021
Q3
Sell
-590
Closed -$2K 985
2021
Q2
$2K Buy
+590
New +$1.92K ﹤0.01% 827
2018
Q4
Sell
-189
Closed -$1K 555
2018
Q3
$1K Sell
189
-7,531
-98% -$35.9K ﹤0.01% 591
2018
Q2
$35K Buy
7,720
+2,028
+36% +$11.9K 0.02% 247
2018
Q1
$41K Sell
5,692
-1,042
-15% -$7.17K 0.02% 220
2017
Q4
$43K Buy
6,734
+118
+2% +$755 0.02% 223
2017
Q3
$43K Buy
6,616
+210
+3% +$1.3K 0.02% 226
2017
Q2
$35K Sell
6,406
-7,409
-54% -$42.3K 0.02% 258
2017
Q1
$79K Buy
13,815
+5,982
+76% +$32.8K 0.04% 153
2016
Q4
$38K Buy
+7,833
New +$42.3K 0.02% 196

Other funds holding ABEV

Arax Advisory Partners's ABEV Position: Q2 2026 in Review

Arax Advisory Partners increased its Ambev (ABEV) stake by 6.7% in Q2 2026, buying an estimated $4.94K and bringing the position to 25,046 shares worth $78.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2907.

Arax Advisory Partners first reported a position in ABEV in Q4 2016 and has held it in 14 quarters since. The position peaked at $79K in Q1 2017. 403 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.

  • Arax Advisory Partners held 25,046 shares of Ambev worth $78.6K as of Q2 2026.
  • Arax Advisory Partners bought 1,580 Ambev shares in Q2 2026, an estimated $4.94K.
  • Ambev made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2907 holding.
  • Arax Advisory Partners first reported a position in Ambev in Q4 2016 and has held it in 14 quarters since.
  • Arax Advisory Partners's Ambev position peaked at $79K in Q1 2017.
  • 403 funds tracked by Wall St. Rank held Ambev as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.